Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 31/03/20221 min de lecture
Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments; Extension of Comment Period
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA, we, or Agency) is extending the comment period for the notice of public hearing that appeared in the Federal Register of January 13, 2022. In the notice, FDA requested comments on scientific data and information related to the residue of carcinogenic concern for the new animal drug carbadox. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →